Neuromodulation has been a fast-growing area of medicine for at least a decade. Despite becoming an increasingly common way to treat chronic pain, neurological disorders, and even psychiatric ...

The neuromodulation devices market is expanding swiftly, propelled by the increasing global incidence of chronic conditions such as pain, epilepsy, and depression. This growth is further supported by ...

First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...

Advances in neuromodulation have improved device performance, but biological markers of pain and treatment response remain poorly defined. Lilac and Soin Neuroscience will test if quantitative RNA ...